FGF-23, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial

CIRCULATION(2023)

引用 0|浏览0
暂无评分
关键词
Cardiovascular Risk,Biomarkers,Diabetes (Type II),Risk Factors,Cardiology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要